Johnson Sandra Marchese, Kincannon Jay M, Dudney Danette L
Central Arkansas Veterans Healthcare System, USA.
J Ark Med Soc. 2004 Sep;101(3):86-90.
Atopic Dermatitis (AD) is a common cutaneous inflammatory disease. Recent estimates of prevalence in United States school children range from 10-20%. Topical treatment of AD is unsatisfactory. Now two new topical agents, tacrolimus and pimecrolimus, are revolutionizing the treatment of AD. Here we review AD as well as these breakthrough therapies.
特应性皮炎(AD)是一种常见的皮肤炎症性疾病。最近对美国学龄儿童患病率的估计在10%至20%之间。AD的局部治疗并不理想。现在,两种新的局部用药,他克莫司和吡美莫司,正在彻底改变AD的治疗方法。在此,我们对AD以及这些突破性疗法进行综述。